Tempus receives FDA clearance for heart condition detection software

Go back to Tempus receives FDA clearance for heart condition detection software
StemCells, Inc. (NASDAQ: TEM) Delayed: 48.61 --0 (-0%)
Previous Close $48.61    52 Week High $0.45 
Open $48.61    52 Week Low $0.37 
Day High $48.61    P/E N/A 
Day Low $48.61    EPS $-0.31 
Volume 31,751